表纸
市场调查报告书

按药物类型,最终用途,用途和用途划分的全球BCG疫苗市场:对COVID-19潜在影响的见解和预测(2020-2024)

Global BCG Vaccine Market (By Drug Type, End Use, Usage & Application): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

出版商 Koncept Analytics 商品编码 941643
出版日期 内容资讯 英文 97 Pages
订单完成后即时交付
价格
按药物类型,最终用途,用途和用途划分的全球BCG疫苗市场:对COVID-19潜在影响的见解和预测(2020-2024) Global BCG Vaccine Market (By Drug Type, End Use, Usage & Application): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
出版日期: 2020年06月11日内容资讯: 英文 97 Pages
简介

在2020年至2024年的预测期内,全球BCG疫苗市场预计将以4.7%的复合年增长率增长,到2024年将达到6553万美元。市场上的主要增长因素是:结核病患病率增加,结核病研究与开发经费增加,膀胱癌的发病率增加,广泛耐药结核病的患病率增加以及卡介苗接种疫苗的覆盖率增加。

本报告调查了全球BCG疫苗市场,包括市场增长因素,市场趋势,挑战,COVID-19影响,按药物类型,最终用户,用途,用途和地区以及竞争进行的市场分析。我们提供有关主要公司的状况和概况的信息。

内容

第1章市场概述

  • 卡介苗疫苗
  • 医疗用途:肺结核
  • 医疗:癌症
  • 医疗:分枝杆菌
  • 卡介苗的给药方法
  • 卡介苗的负面影响
  • 卡介苗预防措施
  • 卡介苗的副作用

第2章COVID-19的影响

  • 对世界经济的影响
  • 自然流量的变化
  • COVID-19的世界时尚

第3章市场分析

  • 按销售量:全球市场
  • 按销售量:全球市场预测
  • 按药物类型
  • 按最终用户
  • 通过使用
  • 通过申请
  • 按地区

第4章区域市场

  • 北美
  • 欧洲
  • 亚太地区
  • 其他地区

第5章市场动态

  • 生长因子
    • 结核病迅速增加
    • 增加结核病研发资金
    • 膀胱癌的发病率增加
    • 美国用于结核病的资金激增
    • 广泛耐药结核的患病率增加
    • 扩大卡介苗接种范围
  • 主要趋势/进展
    • 降低目标结核病发病率
    • 降低了结核病的目标死亡率
  • 挑战
    • BCG对成人的影响有限

第6章竞争情况

  • 世界市场
    • 收入比较:主要公司
    • 市值比较:主要公司
    • 研发成本比较:主要公司
    • 全球市场份额比较:主要公司

第7章公司简介

  • Merck & Co.
  • Sanofi (Sanofi Pasteur)
  • Statens Serum Institut
  • China National Biotec Group (China National Pharmaceutical Group)
  • Serum Institute of India Pvt. Ltd. (SII)
  • Green Signal Bio Pharma Ltd.
目录

The global BCG vaccine market is anticipated to reach US$65.53 million in 2024, growing at a CAGR of 4.70% during the period spanning 2020-2024. Growth in the global BCG vaccine market was driven by factors like increasing prevalence of tuberculosis, rising R&D funding on tuberculosis, growing incidences of bladder cancer, increasing prevalence of extensively drug resistant tuberculosis and surging BCG immunization coverage. The key trends that are expected to be faced by the market are declining targeted incidence rate of tuberculosis and decreasing targeted mortality of tuberculosis. The limited impact of BCG vaccine on adults is expected to impose a challenge on the global BCG vaccine market.

The global BCG vaccine market by drug type can be segmented as follows: immune BCG and therapy BCG. In 2019, the higher share of the market was held by immune BCG. The global BCG vaccine by end user can be segmented into the following pediatrics and adults. The dominant share of the market in 2019 was held by pediatrics. The market by usage can be divided into the following segments: tuberculosis and bladder cancer. The largest share of the market was obtained by tuberculosis in 2019. The global BCG vaccine market by application can be segmented as follows: hospitals and clinics, with hospitals holding a greater share of the market in 2019.

The global BCG vaccine market by region can be segmented into the following regions: North America, Europe and Asia Pacific. In 2019, the dominant share of the market was held by North America, followed by Europe and Asia Pacific. North America is predicted to dominate the market during the period spanning 2020-2024, supported by growing tobacco consumption and increasing technological advancements in BCG vaccination.

Scope of the report:

The report provides a comprehensive analysis of the global BCG vaccine market with potential impact of COVID-19.

The major regional markets (North America, Europe and Asia Pacific) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Merck & Co., Sanofi, Statens Serum Institut, China National Biotec Group (CNBG), Serum Institute of India Pvt. Ltd., Green Signal Bio Pharma Ltd) are also presented in detail.

Key Target Audience:

  • BCG Vaccine Providers/Hospitals
  • API Suppliers
  • End Users (Businesses/Consumers)
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1. BCG Vaccine
  • 1.2. Medical Use: Tuberculosis
  • 1.3. Medical Use: Cancer
  • 1.4. Medical Use: Mycobacteria
  • 1.5. Methods of Administration of BCG
  • 1.6. Adverse Effects of BCG
  • 1.7. Precautions to be taken in BCG
  • 1.8. Side Effects of BCG

2. Impact of COVID-19

  • 2.1. Impact on Global Economy
  • 2.2. Change in Organic Traffic
  • 2.3. Global Prevalence of COVID-19

3. Market Analysis

  • 3.1. Global BCG Vaccine Market by Value
  • 3.2. Global BCG Vaccine Market Forecast by Value
  • 3.3. Global BCG Vaccine Market by Drug Type
    • 3.3.1. Global Immune BCG Market by Value
    • 3.3.2. Global Immune BCG Market Forecast by Value
    • 3.3.3. Global Therapy BCG Market by Value
    • 3.3.4. Global Therapy BCG Market Forecast by Value
  • 3.4. Global BCG Vaccine Market by End User
    • 3.4.1. Global Pediatric BCG Vaccine Market by Value
    • 3.4.2. Global Pediatric BCG Vaccine Market Forecast by Value
    • 3.4.3. Global Adult BCG Vaccine Market by Value
    • 3.4.4. Global Adult BCG Vaccine Market Forecast by Value
  • 3.5. Global BCG Vaccine Market by Usage
    • 3.5.1. Global Tuberculosis BCG Vaccine Market by Value
    • 3.5.2. Global Tuberculosis BCG Vaccine Market Forecast by Value
    • 3.5.3. Global Bladder Cancer BCG Vaccine Market by Value
    • 3.5.4. Global Bladder Cancer BCG Vaccine Market Forecast by Value
  • 3.6. Global BCG Vaccine Market by Application
    • 3.6.1. Global Hospital BCG Vaccine Market Forecast by Value
    • 3.6.2. Global Clinic BCG Vaccine Market Forecast by Value
  • 3.7. Global BCG Vaccine Market by Region

4. Regional Market

  • 4.1. North America
    • 4.1.1. North America BCG Vaccine Market by Value
    • 4.1.2. North America BCG Vaccine Market Forecast by Value
  • 4.2. Europe
    • 4.2.1. Europe BCG Vaccine Market by Value
    • 4.2.2. Europe BCG Vaccine Market Forecast by Value
  • 4.3. Asia Pacific
    • 4.3.1. Asia Pacific BCG Vaccine Market by Value
    • 4.3.2. Asia Pacific BCG Vaccine Market Forecast by Value
  • 4.4. ROW
    • 4.4.1. ROW BCG Vaccine Market by Value
    • 4.4.2. ROW BCG Vaccine Market Forecast by Value

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Surging Prevalence of Tuberculosis
    • 5.1.2. Increasing Research & Development Funding on Tuberculosis
    • 5.1.3. Rising Incidence of Bladder Cancer
    • 5.1.4. Upsurge in the US Funding for Tuberculosis
    • 5.1.5. Rising Prevalence of Extensively Drug-Resistant Tuberculosis
    • 5.1.6. Increasing BCG Immunization Coverage
  • 5.2. Key Trends & Developments
    • 5.2.1. Declining Targeted Incidence Rate of Tuberculosis
    • 5.2.2. Decreasing Targeted Mortality of Tuberculosis
  • 5.3. Challenges
    • 5.3.1. Limited Impact of BCG on Adults

6. Competitive Landscape

  • 6.1. Global Market
    • 6.1.1. Revenue Comparison- Key Players
    • 6.1.2. Market Capitalization Comparison- Key Players
    • 6.1.3. Research & Development Expenses Comparison - Key Players
    • 6.1.4. Global BCG Market Share Comparison - Key Players

7. Company Profiles

  • 7.1. Merck & Co.
    • 7.1.1. Business Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. Sanofi (Sanofi Pasteur)
    • 7.2.1. Business Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. Statens Serum Institut
    • 7.3.1. Business Overview
    • 7.3.2. Business Strategies
  • 7.4. China National Biotec Group (China National Pharmaceutical Group)
    • 7.4.1. Business Overview
    • 7.4.2. Business Strategies
  • 7.5. Serum Institute of India Pvt. Ltd. (SII)
    • 7.5.1. Business Overview
    • 7.5.2. Business Strategies
  • 7.6. Green Signal Bio Pharma Ltd.
    • 7.6.1. Business Overview
    • 7.6.2. Business Strategies

List of Charts

  • Medical Uses of BCG Vaccine
  • Medical Use of BCG: Mycobacteria
  • Medical Use of BCG: Mycobacteria
  • Side Effects of BCG
  • Organic Traffic Growth or Decline due to COVID-19 (2020)
  • Global COVID-19 Infected Cases (Jan'20 - May'20)
  • Global BCG Vaccine Market by Value (2015-2019)
  • Global BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Drug Type (2019)
  • Global Immune BCG Market by Value (2015-2019)
  • Global Immune BCG Market Forecast by Value (2020-2024)
  • Global Therapy BCG Market by Value (2015-2019)
  • Global Therapy BCG Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by End User (2019)
  • Global Pediatric BCG Vaccine Market by Value (2015-2019)
  • Global Pediatric BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Adult BCG Vaccine Market by Value (2015-2019)
  • Global Adult BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Usage (2019)
  • Global Tuberculosis BCG Vaccine Market by Value (2015-2019)
  • Global Tuberculosis BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Bladder Cancer BCG Vaccine Market by Value (2015-2019)
  • Global Bladder Cancer BCG Vaccine Market Forecast by Value (2020-2024)
  • Global BCG Vaccine Market by Application (2019)
  • Global Hospital BCG Vaccine Market Forecast by Value (2019-2024)
  • Global Clinic BCG Vaccine Market Forecast by Value (2019-2024)
  • Global BCG Vaccine Market by Region (2019)
  • North America BCG Vaccine Market by Value (2015-2019)
  • North America BCG Vaccine Market Forecast by Value (2020-2024)
  • Europe BCG Vaccine Market by Value (2015-2019)
  • Europe BCG Vaccine Market Forecast by Value (2020-2024)
  • Asia Pacific BCG Vaccine Market by Value (2015-2019)
  • Asia Pacific BCG Vaccine Market Forecast by Value (2020-2024)
  • ROW BCG Vaccine Market by Value (2015-2019)
  • ROW BCG Vaccine Market Forecast by Value (2020-2024)
  • Global Prevalence of Tuberculosis (2014-2019)
  • Global TB Research & Development Funding (2013-2019)
  • Global Incidence of Bladder Cancer (2014-2019)
  • The US Funding for Global Tuberculosis (2014-2020)
  • Global Prevalence of Extensively Drug-Resistant Tuberculosis (2014-2019)
  • Global BCG Immunization Coverage Rate (2014-2019)
  • Global Targeted Incidence Rate of Tuberculosis (2015-2035)
  • Global Targeted Mortality of Tuberculosis (2015-2035)
  • Key Players - Revenue Comparison (2019)
  • Key Players - Market Capitalization Comparison (2020)
  • Key Players - R&D Expenses Comparison (2019)
  • Key Players - Global BCG Market Share Comparison (2019)
  • Merck & Co. Sales & Net Income (2015-2019)
  • Merck & Co. Sales by Segment (2019)
  • Merck & Co. Sales by Region (2019)
  • Sanofi Net Sales & Net Income (2015-2019)
  • Sanofi Net Sales by Segment (2019)
  • Sanofi Net Sales by Region (2019)